Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone

International Journal of Infectious Diseases

Volumn 17, Issue 6, 2013, Pages

  Shuel, Michelle ^a   Jamieson, Frances B ^b,c   Tang, Patrick ^b   Brown, Shirley ^b   Farrell, David ^b,c   Martin, Irene ^a   Stoltz, Jan ^a   Tsang, Raymond S W ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bordetella pertussis; Fim3B; PFGE; Prn2; PtxP3

Indexed keywords

PERTACTIN; PERTUSSIS TOXIN; VIRULENCE FACTOR;

ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; CANADA; DNA SEQUENCE; EUROPE; FIMBRIA; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PERTUSSIS; PROMOTER REGION; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING;

BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; CLUSTER ANALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; ONTARIO; SEROTYPING; VIRULENCE FACTORS; WHOOPING COUGH;

EID: 84877138822     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.12.015     Document Type: Article

References (32)

1. Halperin S.A., Wang E.E., Law B., Mills E., Morris R., Dery P., et al. Epidemiology features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999, 28:1238-1243.
2. Waters V., Jamieson F., Richardson S.E., Finkelstein M., Wormsbecker A., Halperin S.A. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J 2009, 28:582-587.
3. Varughese P. Incidence of pertussis in Canada. Can Med Assoc J 1985, 132:1041-1042.
4. Halperin S.A., Bortolussi R., MacLean D., Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia enhanced pertussis surveillance program. J Pediatrics 1989, 115:686-693.
5. Skrowronski D.M., De Serres G., MacDonald D., Wu W., Shaw C., Macnabb J., et al. The changing age and season profile of pertussis in Canada. J Infect Dis 2003, 185:1448-1453.
6. Rohani P., Zhong X., King A.A. Contact network structure explains the changing epidemiology of pertussis. Science 2010, 330:982-985.
7. Fry N.K., Neal S., Harrison T.G., Miller E., Matthews R., George R.C. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun 2001, 69:5520-5528.
8. Gzyl A., Augustynowic E., van Loo I., Slusarczyl J. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 2001, 20:299-303.
9. Mooi F.R., von Oirschot H., Heuvelman K., van der Heide H.G., Gaastra W., Willems R.J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998, 66:670-675.
10. Cassiday P., Sanden G., Heuvelman K., Mooi F., Bisgard K.M., Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2009, 182:1402-1408.
11. Mooi F.R., van Loo I.H., van Gent M., He Q., Bart M.J., Heuvelman K.J., et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009, 15:1203-1213.
12. von Konig C.H., Riffelmann M., Coenye T. Bordetella and related genera. Manual of clinical microbiology 2010, 739-750. ASM Press, Washington, DC. 10th ed. J. Versalovic, K.C. Carroll, J.H. Jorgensen, G. Funke, M.L. Landry, D.W. Warnock (Eds.).
13. Tsang R.S., Sill M.L., Advani A., Xing D., Newland P., Hallander H. Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole cell enzyme-linked immunosorbent assay and bacterial microagglutination methods. J Clin Microbiol 2005, 43:2449-2451.
14. Van Loo I.H., Heuvelman K.J., King A.J., Mooi F.R. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 2002, 40:1994-2001.
15. Tsang R.S., Lau A.K., Sill M.L., Haperin S.A., Van Caeseele P., Jamieson F., et al. Polymorphisms of the fimbriae fim3 gene in Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004, 42:5364-5367.
16. Tsang R.S., Sill M.L., Martin I.E., Jamieson F. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine. Can J Microbiol 2005, 10:887-892.
17. Weber C., Boursaux-Eude C., Coralie G., Caro V., Guiso N. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001, 39:1396-1403.
18. Mooi F.R., Hallander H., von Konig C.H., Hoet B., Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 2000, 19:174-181.
19. Advani A., Donnelly D., Hallander H. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol 2004, 42:2890-2897.
20. Hallander H., Advani A., Riffelmann M., von Konig C.H., Caro V., Guiso N., et al. Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol 2007, 45:3257-3262.
21. Fisman D.N., Tang P., Hauck T., Richardson S., Drews S.J., Low D.E., et al. Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modelling. BMC Public Health 2011, 11:694.
22. Elomaa A., Advani A., Donnelly D., Antila M., Mertsola J., He Q., et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 2007, 25:918-926.
23. Advani A., Gustafsson L., Carlsson R.M., Donnelly D., Hallander H. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS 2007, 115:736-742.
24. Advani A., Van der Heide H.G., Hollander H.O., Mooi F.R. Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods 2009, 78:297-301.
25. Advani A., Donnelly D., Gustafsson L., Hallander H.O. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. APMIS 2007, 115:299-310.
26. Carbonetti M.H., Artamonova G.V., Van Rooijen N., Ayala V.I. Pertussis toxin targets airway macrophages to promote B. pertussis infection of the respiratory tract. Infect Immun 2007, 75:1713-1720.
27. Kirimanjeswara G.S., Agosto L.M., Kennett M.J., Bjornstad O.N., Harvill E.T. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 2005, 115:3594-3601.
28. Schouls L., van der Heide H., Witteveen S., Zomer B., van der Ende A., Burger M., et al. Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA, and hcsB genes display differences in expression of the polysaccharide capsule. BMC Microbiol 2008, 8:35.
29. Uria M.J., Zhang Q., Li Y., Chan A., Exley R.M., Gollan B., et al. A genetic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med 2008, 205:1423-1434.
30. Mooi F.R., He Q., van Oirschut H., Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun 1999, 67:3133-3134.
31. He Q., Makinen J., Berbers G., Mooi F.R., Viljanen M.K., Arvilommi H. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants?. J Infect Dis 2003, 187:1200-1205.
32. Octavia S., Sintchenko V., Gilbert G.L., Lawrence A., Keil A.D., Hogg G., et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic 2008-2010. J Infect Dis 2012, 205:1220-1224.